A.S.P.E.N. Clinical Guidelines: Nutrition Support of Children With Human Immunodeficiency Virus Infection

Abstract

Get full access to this article

View all access options for this article.

References

A.S.P.E.N. Board of Directors. Guidelines for use of total parenteral nutrition in the hospitalized adult patient. JPEN J Parenter Enteral Nutr.1986 ;10(5):441 -445.

A.S.P.E.N. Board of Directors. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr. 2002;26(1 suppl): 1SA-138SA.

A.S.P.E.N. Board of Directors. Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients. JPEN J Parenter Enteral Nutr. 1993;17(suppl 4): 1SA-52SA.

Committee to Advise Public Health Service on Clinical Practice Guidelines (Institute of Medicine). Clinical Practice Guidelines: Directions for a New Program. Washington, DC: National Academy Press;1990 : 58.

Seres D, Compher C, Seidner D, Byham-Gray L, Gervasio J, McClave S. 2005 American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Standards and Guidelines survey. Nutr Clin Pract.2006 ;21(5):529 -532.

Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32(3):858 -873.

Guyatt GH, Haynes RB, Jaeschke RZ, et al. Users' Guides to the Medical Literature, XXV: evidence-based medicine: principles for applying the Users' Guides to patient care. Evidence-Based Medicine Working Group.JAMA .2000 ;284(10):1290 -1296.

Bailey RC, Kamenga MC, Nsuami MJ, Nieburg P, St Louis ME. Growth of children according to maternal and child HIV, immunological and disease characteristics: a prospective cohort study in Kinshasa, Democratic Republic of Congo. Int J Epidemiol.1999 ;28(3):532 -540.

McKinney RE Jr, Robertson JW. Effect of human immunodeficiency virus infection on the growth of young children. Duke Pediatric AIDS Clinical Trials Unit. J Pediatr.1993 ;123(4):579 -582.

10.

Miller TL, Easley KA, Zhang W, et al. Maternal and infant factors associated with failure to thrive in children with vertically transmitted human immunodeficiency virus-1 infection: the prospective, P2C2 human immunodeficiency virus multicenter study. Pediatrics.2001 ;108(6):1287 -1296.

11.

CDC. 1994 Revised classification system for human immunodeficiency infection in children less than 13 years of age. In: MMWR, ed. Vol. 43: Centers for Disease Control Surveillance Summary; 1994:1 -9.

12.

Berhane R, Bagenda D, Marum L, et al. Growth failure as a prognostic indicator of mortality in pediatric HIV infection.Pediatrics .1997 ;100(1):E7 .

13.

Lepage P, Msellati P, Hitimana DG, et al. Growth of human immunodeficiency type 1-infected and uninfected children: a prospective cohort study in Kigali, Rwanda, 1988 to 1993. Pediatr Infect Dis J.1996 ;15(6):479 -485.

14.

Villamor E, Misegades L, Fataki MR, Mbise RL, Fawzi WW. Child mortality in relation to HIV infection, nutritional status, and socioeconomic background. Int J Epidemiol.2005 ;34(1):61 -68.

15.

Newell ML, Borja MC, Peckham C. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe.Pediatrics .2003 ;111(1):e52 -e60.

16.

Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. Pediatrics.2002 ;109(2):E25 .

17.

Miller TL, Mawn BE, Orav EJ, et al. The effect of protease inhibitor therapy on growth and body composition in human immunodeficiency virus type 1-infected children. Pediatrics.2001 ;107(5):E77 .

18.

Miller TL, Evans SJ, Orav EJ, Morris V, McIntosh K, Winter HS. Growth and body composition in children infected with the human immunodeficiency virus-1. Am J Clin Nutr.1993 ;57(4):588 -592.

19.

Taylor P, Worrell C, Steinberg SM, et al. Natural history of lipid abnormalities and fat redistribution among human immunodeficiency virus-infected children receiving long-term, protease inhibitor-containing, highly active antiretroviral therapy regimens. Pediatrics.2004 ;114(2):e235 -e242.

20.

Jaquet D, Levine M, Ortega-Rodriguez E, et al. Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children. AIDS.2000 ;14(14):2123 -2128.

21.

Arpadi SM, Horlick MN, Wang J, Cuff P, Bamji M, Kotler DP. Body composition in prepubertal children with human immunodeficiency virus type 1 infection. Arch Pediatr Adolesc Med.1998 ;152(7):688 -693.

22.

Rollins NC, van den Broeck J, Kindra G, Pent M, Kasambira T, Bennish ML. The effect of nutritional support on weight gain of HIV-infected children with prolonged diarrhoea. Acta Paediatr.2007 ;96(1):62 -68.

23.

Miller TL, Awnetwant EL, Evans S, Morris VM, Vazquez IM, McIntosh K. Gastrostomy tube supplementation for HIV infected children.Pediatrics .1995 ;96(4 Pt 1):696 -702.

24.

Henderson RA, Saavedra JM, Perman JA, Hutton N, Livingston RA, Yolken RH. Effect of enteral tube feeding on growth of children with symptomatic human immunodeficiency virus infection. J Pediatr Gastroenterol Nutr.1994 ;18(4):429 -434.

25.

Amadi B, Mwiya M, Chomba E, et al. Improved nutritional recovery on an elemental diet in Zambian children with persistent diarrhoea and malnutrition. J Trop Pediatr.2005 ;51(1):5 -10.

26.

Guillen S, Ramos JT, Resino R, Bellon JM, Munoz MA. Impact on weight and height with the use of HAART in HIV+ children. Pediatr Infect Dis J.2007 ;26(4):334 -338.

27.

Scherpbier HJ, Bekker V, van Leth F, Jurriaans S, Lange JM, Kuijpers TW. Long-term experience with combination antiretroviral therapy that contains nelfinavir for up to 7 years in a pediatric cohort.Pediatrics .2006 ;117(3):e528 -e536.

28.

Nachman SA, Lindsey JC, Moye J, et al. Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy. Pediatr Infect Dis J.2005 ;24(4):352 -357.

29.

Arpadi SM. Growth failure in children with HIV infection. J Acquir Immune Defic Syndr.2000 ;25(suppl 1):S37 -S42.

30.

Ene L, Goetghebuer T, Hainaut M, Peltier A, Toppet V, Levy J. Prevalence of lipodystrophy in HIV+ children: a cross-sectional study.Eur J Pediatr .2007 ;166(1):13 -21.

31.

Sanchez Torres AM, Munoz Muniz R, Madero R, Borque C, Garcia-Miguel MJ, De Jose Gomez MI. Prevalence of fat redistribution and metabolic disorders in human immunodeficiency virus-infected children. Eur J Pediatr.2005 ;164(5):271 -276.

32.

Carter RJ, Wiener J, Abrams EJ, et al. Dyslipidemia among perinatally HIV+ children enrolled in the PACTS-HOPE cohort, 1999-2004: a longitudinal analysis. J Acquir Immune Defic Syndr.2006 ;41(4):453 -460.

33.

Beregszaszi M, Dollfus C, Levine M, et al. Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV+ children. J Acquir Immune Defic Syndr.2005 ;40(2):161 -168.

34.

Farley J, Gona P, Crain M, et al. Prevalence of elevated cholesterol and associated risk factors among perinatally HIV+ children (4-19 years old) in Pediatric AIDS Clinical Trials Group 219C. J Acquir Immune Defic Syndr.2005 ;38(4):480 -487.

35.

Arpadi SM, Cuff PA, Kotler DP, et al. Growth velocity, fat-free mass and energy intake are inversely related to viral load in HIV+ children.J Nutr .2000 ;130(10):2498 -2502.

36.

Amaya RA, Kozinetz CA, McMeans A, Schwarzwald H, Kline MW. Lipodystrophy syndrome in human immunodeficiency virus-infected children.Pediatr Infect Dis J .2002 ;21(5):405 -410.

37.

Hartman K, Verweel G, de Groot R, Hartwig NG. Detection of lipoatrophy in human immunodeficiency virus-1-infected children treated with highly active antiretroviral therapy. Pediatr Infect Dis J.2006 ;25(5):427 -431.

38.

Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV+ children in Europe. Aids.2004 ;18(10):1443 -1451.

39.

Fawzi WW, Hunter DJ. Vitamins in HIV disease progression and vertical transmission. Epidemiology.1998 ;9(4):457 -466.

40.

Fawzi WW, Msamanga GI, Spiegelman D, et al. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet.1998 ;351(9114):1477 -1482.

41.

McGrath N, Bellinger D, Robins J, Msamanga GI, Tronick E, Fawzi WW. Effect of maternal multivitamin supplementation on the mental and psychomotor development of children who are born to HIV-1-infected mothers in Tanzania.Pediatrics .2006 ;117(2):e216 -e225.

42.

Villamor E, Saathoff E, Bosch RJ, et al. Vitamin supplementation of HIV+ women improves postnatal child growth. Am J Clin Nutr.2005 ;81(4):880 -888.

43.

Fawzi WW, Villamor E, Msamanga GI, et al. Trial of zinc supplements in relation to pregnancy outcomes, hematologic indicators, and T cell counts among HIV-1-infected women in Tanzania. Am J Clin Nutr.2005 ;81(1):161 -167.

44.

Humphrey JH, Iliff PJ, Marinda ET, et al. Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality.J Infect Dis .2006 ;193(6):860 -871.

45.

Humphrey JH, Hargrove JW, Malaba LC, et al. HIV incidence among post-partum women in Zimbabwe: risk factors and the effect of vitamin A supplementation. AIDS.2006 ;20(10):1437 -1446.

46.

Kumwenda N, Miotti PG, Taha TE, et al. Antenatal vitamin A supplementation increases birth weight and decreases anemia among infants born to human immunodeficiency virus-infected women in Malawi. Clin Infect Dis. 2002;35(5):618 -624.

47.

Coutsoudis A, Pillay K, Spooner E, Kuhn L, Coovadia HM. Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa. South African Vitamin A Study Group. AIDS.1999 ;13(12):1517 -1524.

48.

Fawzi WW, Msamanga GI, Hunter D, et al. Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breastfeeding and early child mortality. AIDS.2002 ;16(14):1935 -1944.

49.

Wiysonge CS, Shey MS, Sterne JA, Brocklehurst P. Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev.2005 ;(4):CD003648 .

50.

Fawzi WW, Msamanga GI, Wei R, et al. Effect of providing vitamin supplements to human immunodeficiency virus-infected, lactating mothers on the child's morbidity and CD4+ cell counts. Clin Infect Dis.2003 ;36(8):1053 -1062.

51.

Kruzich LA, Marquis GS, Carriquiry AL, Wilson CM, Stephensen CB. US youths in the early stages of HIV disease have low intakes of some micronutrients important for optimal immune function. J Am Diet Assoc. 2004;104(7):1095 -1101.

52.

Jacobson DL, Spiegelman D, Duggan C, et al. Predictors of bone mineral density in human immunodeficiency virus-1 infected children. J Pediatr Gastroenterol Nutr.2005 ;41(3):339 -346.

53.

Campa A, Shor-Posner G, Indacochea F, et al. Mortality risk in selenium-deficient HIV-positive children. J Acquir Immune Defic Syndr Hum Retrovirol.1999 ;20(5):508 -513.

54.

Fawzi WW, Mbise RL, Hertzmark E, et al. A randomized trial of vitamin A supplements in relation to mortality among human immunodeficiency virus-infected and uninfected children in Tanzania. Pediatr Infect Dis J. 1999;18(2):127 -133.

55.

Coutsoudis A, Bobat RA, Coovadia HM, Kuhn L, Tsai WY, Stein ZA. The effects of vitamin A supplementation on the morbidity of children born to HIV+ women. Am J Public Health.1995 ;85(8 pt 1):1076 -1081.

56.

Bobat R, Coovadia H, Stephen C, et al. Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial. Lancet.2005 ;366(9500):1862 -1867.

57.

Tremeschin MH, Cervi MC, Camelo Júnior JS, et al. Niacin nutritional status in HIV type 1-positive children: preliminary data. J Pediatr Gastroenterol Nutr.2007 ;44(5):629 -633.

58.

Semba RD, Ndugwa C, Perry RT, et al. Effect of periodic vitamin A supplementation on mortality and morbidity of human immunodeficiency virus-infected children in Uganda: a controlled clinical trial.Nutrition .2005 ;21(1):25 -31.

59.

Nduati R, John G, Mbori-Ngacha D, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial.JAMA .2000 ;283(9):1167 -1174.

60.

Iliff PJ, Piwoz EG, Tavengwa NV, et al. Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS.2005 ;19(7):699 -708.

61.

Dunn DT, Newell ML, Ades AE, Peckham CS. Risk of human immunodeficiency virus type 1 transmission through breastfeeding.Lancet .1992 ;340(8819):585 -588.

62.

Kourtis AP, Jamieson DJ, de Vincenzi I, et al. Prevention of human immunodeficiency virus-1 transmission to the infant through breastfeeding: new developments. Am J Obstet Gynecol.2007 ;197(3 suppl):S113 -S122.

63.

WHO UUU. Report of a technical consultation held on behalf of the Inter-agency Task Team (IATT) on Prevention of HIV infections in pregnant women, mother and their infants. Paper presented at: HIV and infant feeding: new evidence and programmatic experience;October 2006; Geneva, Switzerland.

64.

Bulteel N, Henderson P. Evidence behind the WHO guidelines: hospital care for children: what are the risks of formula feeding in children of HIV+ mothers? J Trop Pediatr.2007 ;53(6):370 -373.

65.

Bulteel N, Henderson P. Evidence behind the WHO guidelines: hospital care for children: what are the risks of HIV transmission through breastfeeding? J Trop Pediatr.2007 ;53(5):298 -302.

66.

Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F. Mortality of infected and uninfected infants born to HIV+ mothers in Africa: a pooled analysis. Lancet.2004 ;364(9441):1236 -1243.

67.

Coovadia HM, Rollins NC, Bland RM, et al. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet.2007 ;369(9567):1107 -1116.

68.

Becquet R, Ekouevi DK, Menan H, et al. Early mixed feeding and breastfeeding beyond 6 months increase the risk of postnatal HIV transmission: ANRS 1201/1202 Ditrame Plus, Abidjan, Cote d'Ivoire. Prev Med.2008 ;47(1):27 -33.

69.

Rollins NC, Becquet R, Bland RM, Coutsoudis A, Coovadia HM, Newell ML. Infant feeding, HIV transmission and mortality at 18 months: the need for appropriate choices by mothers and prioritization within programmes.AIDS .2008 ;22(17):2349 -2357.

70.

Kuhn L, Aldrovandi GM, Sinkala M, et al. Effects of early, abrupt weaning on HIV-free survival of children in Zambia. N Engl J Med. 2008;359(2):130 -141.

71.

Palombi L, Marazzi MC, Voetberg A, Magid NA. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV. AIDS.2007 ;21(suppl 4):S65 -S71.

72.

Taha TE, Hoover DR, Kumwenda NI, et al. Late postnatal transmission of HIV-1 and associated factors. J Infect Dis.2007 ;196(1):10 -14.

73.

Thior I, Lockman S, Smeaton LM, et al. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA.2006 ;296(7):794 -805.

74.

Coutsoudis A, Pillay K, Spooner E, Coovadia HM, Pembrey L, Newell ML. Morbidity in children born to women infected with human immunodeficiency virus in South Africa: does mode of feeding matter? Acta Paediatr.2003 ;92(8):890 -895.